Asan Medical Center CCTA Registry

Completed

• Conditions: Coronary Artery Disease; Risk Factor; Computed Tomography

• Registration Number: NCT06036901
• Lead Sponsor: CardioVascular Research Foundation, Korea

Brief Summary

A total of 9269 adults who received CCTA scans for coronary disease evaluation during a general medical checkup at the Health Screening and Promotion Center in Asan Medical Center, Seoul, Korea between January 2007 and December 2011 were initially selected. All participants were provided with information about the potential benefits and risks of CCTA and made the decision to undergo the procedure at their own expense. They were also informed that their clinical and radiological data would be used for this study and gave their consent. Of these individuals, 7129 agreed to participate, and 6343 were enrolled in this CCTA registry.

Detailed Description

Not available

Study Timeline

• Study Start: 2007-01-01
• Primary Completion: 2011-12-31
• Study Completion: 2022-12-31
• Study First Submitted: 2023-08-15
• Status Verified: 2023-09
• Study First Submitted QC: 2023-09-12
• Last Update Submitted: 2023-09-12
• Study First Posted: 2023-09-14
• Last Update Posted: 2023-09-14

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 6343

Inclusion Criteria

Not provided

Exclusion Criteria

1. a previous history of angina or myocardial infarction;
2. abnormal rest electrocardiographic results, i.e., pathological Qwaves, ischemic ST segments or T wave changes, or left bundle-branch blocks;
3. insufficient medical records;
4. structural heart diseases;
5. a prior history of open heart surgery or percutaneous coronary intervention;
6. a previous cardiac procedure; or
7. renal insufficiency (creatinine N1.5 mg/dL)

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The prevalence of CAD	5 years	Diameter stenosis \>50% in any coronary artery by coronary CT angiography

Secondary Outcome Measures

Name	Time	Method
Revascularization	5 years	Number of participants with any percutaneous or surgical revascularization procedure during follow-up.
cardiovascular mortality	5 years	any death caused by a cardiovascular problem or if there was no identified cause of death
All cause mortality	5 years
myocardial infarction	5 years	Number of participants with an increase in cardiac enzyme above the upper reference limit with ischemic symptoms or signs.